Author

Scott R. Wright

Observed names: Scott R Wright, Scott Wright

Observed institution: Mayo Clinic

OpenAlex ID: A5110885652

Draft toxicological profile for cadmium

2008 · Annette Ashizawa, Obaid Faroon, et al. · 109

Relation of Body Mass Index to Fatal and Nonfatal Cardiovascular Events After Cardiac Rehabilitation

2005 · Justo Sierra-Johnson, Scott R. Wright, et al. · The American Journal of Cardiology · 38

A patient with hypertrophic obstructive cardiomyopathy presenting with left ventricular apical ballooning syndrome.

2006 · Wissam A Jaber, Scott R Wright, et al. · PubMed · 16

Chronic Traumatic Aneurysm of the Left Main Coronary Artery Causing Myocardial Infarction

2005 · Dumbor L. Ngaage, Sumeet K. Singh, et al. · The Annals of Thoracic Surgery · 4

Table 2-3, Selected Studies of Dose-Response Relationship for Cadmium-Induced Low Molecular Weight Proteinuria

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 2-1, Summary of Human Studies Finding Dose-Response Relationships Between Biomarkers of Renal Dysfunction and Cadmium Exposure

2012 · Obaid Faroon, Annette Ashizawa, et al.

Figure 2-3, Urinary Cadmium (µg/g creatinine) and Renal Cortex Cadmium Concentration (µg/g wet tissue) Predicted by the Cadmium Pharmacokinetic Model*

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-8, Benchmark Dose Estimations of Urinary Cadmium Levels (µg/g Creatinine)

2012 · Obaid Faroon, Annette Ashizawa, et al.

Figure 2-1, Combined Chronic Oral Cadmium Intakes (µg/kg/day) and Inhalation Cadmium Exposures (µg/m3) that Achieve a Urinary Excretion of 0.5 µg/g Creatinine at Age 55 Years Predicted by the Cadmium Pharmacokinetic Model International Commission on Radiological Protection (ICRP) Human Respiratory Tract Model*

2012 · Obaid Faroon, Annette Ashizawa, et al.

Figure 2-2, Estimates of the UCD10 from Environmental Exposure Dose-Response Studies*

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 2-2, Selected Benchmark Dose Estimations of Urinary Cadmium Levels Associated with Increases in the Prevalence of Low Molecular Weight Proteinuria

2012 · Obaid Faroon, Annette Ashizawa, et al.

[Table, ATSDR MINIMAL RISK LEVELS AND WORKSHEETS].

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-13, Estimated Parameters, Rate of Uptake, Rate Constants, and Biological Half-Lives in Selected Mouse Organs After Subcutaneous and Oral Administrations of 109CdCI2

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 7-3, Ongoing Analytical Methods Studies on Cadmium

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-11, Genotoxicity of Cadmium In Vitro

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-2, Comparison of Lung Effects Across Intermediate-Duration Inhalation Studies

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-4, Summary of Occupational Exposure Studies Examining Renal Effects

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 5-1, Facilities that Produce, Process, or Use Cadmium

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-12, Assumed Model Parameters and Some Physiologic Parameters for the Nordberg-Kjellström Model

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-10, Genotoxicity of Cadmium In Vivo

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-9, Levels of Significant Exposure to Cadmium - Dermal

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-7, Summary of Human Studies Examining Renal Effects

2012 · Obaid Faroon, Annette Ashizawa, et al.

Figure 3-2, Levels of Significant Exposure to Cadmium - Oral

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-3, Severity of Respiratory Effects in Rats and Mice Exposed to Cadmium Oxide for 13 Weeksa

2012 · Obaid Faroon, Annette Ashizawa, et al.

Table 3-14, Ongoing Studies on Cadmium

2012 · Obaid Faroon, Annette Ashizawa, et al.

Works count: 29

Citation count: 167

H-index: 4

I10-index: 3